Staphylococcus aureus is an important human pathogen, and identification is generally based on clumping factor and staphylocoagulase production. In fact, among isolates from humans, staphylocoagulase and clumping factor are produced only by strains belonging to this species (11) . Despite their wide diffusion, the evaluation of these tests is more critical than it is generally thought, and examples of falsepositive and false-negative results are well known (7, 11, 15, 20, 21, 29, 30) . Moreover, when animal origin strains are considered, it is evident that other species share the abovementioned properties with S. aureus (staphylocoagulase is also produced by Staphylococcus intermedius, Staphylococcus delphini, and some Staphylococcus hyicus strains [6, 9, 26] , while clumping factor is also produced by some S. intermedius isolates [9] ). Thus, even if both tests continue to be the most widely used S. aureus identification systems, there is the need for developing more-accurate, non-timeconsuming assays.
In previous works, the taxonomy of the family Micrococcaceae has been treated by a new approach based on the analysis of the bacteriolytic activity produced by the strains (19, 27) . In particular, six different groups of human origin staphylococci, called lyogroups, have been recognized on the basis of their bacteriolytic patterns analyzed with an appropriate assay system (28) . Subsequent investigations have shown very close relationships between staphylococcal lyogroups and species recognized according to physiological and biochemical properties and led to a simplified system for routine identification of the lyogroups (25 In this paper we describe the selection of a MAb which specifically reacts with SaG. This MAb was utilized to develop an immunoenzymatic assay that, combining antibody ability to react with protein A and SaG, is a very accurate S. aiureus identification system. This tcst was shown to be very useful for the identification of those strains that, being negative either for clumping factor or for staphylocoagulase or protein A, represent a problem when conventional identification methods are used (7, 11, 15, 20, 21, 29, 30) .
MATERLALS AND METHODS
Bacterial strains. Staphylococcal strains belonging to the collections of the Microbiology Institutes of Genova, Ancona, and Siena Universities werc utilized throughout this study. Strains were assigned to the various species by standard biochemical tests (11) (14) .
Detection of bacteriolytic activity production. Strains grown in BHIB to the logarithmic phase were spotted onto BHIA plates containing heat-killed M. litelis at a final concentration of 5 x 107 cells ml-'. After overnight incubation at 37°C, bacteriolytic activity was indicated by a zone of transparency around spots.
Purification of bacteriolytic enzymes. Bacteriolytic enzymes secreted by S. aurelis, S. simulans, and S. saprophyticius were purified and their lytic activities were measured as previously described (23) .
MAb production and purification. Hybridoma-producing MAbs against SaG have been developed by standard procedures (1) Protein concentration was estimated from spectrophotometric measurements of the A28,, and by the Lowry procedure as modified by Sanderman and Strominger (17) .
Immunoenzymatic assay on nitrocellulose. A pool of colonies of strains grown overnight on BHIA and collected with toothpick, 20 p.1 of whole broth cultures grown overnight in BHIB, or 20 ,ul of supernatant obtained after centrifugation of the above-described cultures at 3,000 x g for 15 Also in Table 1 , results obtained with two protein A-positive strains are reported. As expected, colonies, broth cultures, and supernatants were positive in the immunoenzymatic assay (starting from the MAb concentration of 1 ,ug/ml). Positive results were also obtained in the controls, in which MAbs of different specificities were used, thus indicating that the MAbs also reacted, through the Fc fragment, with protein A.
Use of the Ci-10/11 MAb for the identification of S. aureus strains. The results suggested the possibility to utilize the immunoenzymatic assay to identify S. aureus isolated from clinical specimens. We studied the test sensitivity by per- forming it with a large number of S. aureus isolates and its ability to differentiate S. aureus from other staphylococci by performing the assay with strains belonging to other species.
As shown in Table 2 , 8 of 192 S. aureus strains were protein A negative; 6 of them were also negative for the clumping factor, a property that is often utilized for the rapid identification of S. aureus; and 4 were also negative for the staphylocoagulase, the most widely used identificative characteristic of this microorganism. Clumping factor was also not produced by 16 protein A-positive isolates, 3 of which were negative for the staphylocoagulase, too. The immunoenzymatic assay performed by colony blotting gave positive results with all of the tested strains, thus demonstrating its high sensitivity (100%).
A total of 277 non-S. aureus isolates were then analyzed for the ability to react with Cl-10/11 MAb (at a final concentration of 10 The high sensitivity of the assay is based on the antibody's simultaneous binding of SaG and protein A, the former through the Fab domain and the latter through the Fc fragment. This last reaction, also utilized by many commercial S. aureus identification tests (2-5, 11), would not be sufficient alone to correctly identify all isolates, since up to 10% of S. aureus strains lack this protein (8, (12) (13) (14) 31) . In this study 10 of 196 S. aureus strains tested (Tables 1 and 2) were protein A negative; despite this, they yielded positive immunoenzymatic results as a consequence of the SaG detection by the Cl-10/11 MAb. In fact, this enzyme is produced by all S. aureus strains (27, 28) ; to our knowledge no wild-type strain lacking such bacteriolytic activity has been isolated. More recently it has also been shown that SaG is an S. aureus virulence factor and interferes with several aspects of vertebrate cell physiology (22, 24) .
The ability to differentiate S. aureus isolates from strains belonging to other staphylococcal species is based on the fact that although all staphylococci produce bacteriolytic enzymes sharing the same specificity of action, these proteins differ in many chemical-physical properties (molecular weight, kinetic of activity, and stability, etc.) (23) . In the present work 277 non-S. aureus isolates were shown to be negative by the Cl-10/11 immunoenzymatic assay, also excluding a reaction through protein A that, according to some authors, could be infrequently, if ever, produced by some non-S. aureus species (8) . It is interesting to point out also that the S. hyicus and S. intermedius isolates that, producing staphylocoagulase (6, 9) , could be confused with S. aureus yielded negative results.
Other advantages of this test over the usual biochemical identification methods are the reduced execution time (only 3 to 5 h) and the possibility to test several strains simultaneously. In conclusion, the assay here presented could be used as a single identification test for S. aureus strains, particularly those clumping factor, staphylocoagulase, or protein A negative. Moreover, this study can be the starting point for a novel approach to the identification of other important pathogenic bacteria. In fact, it has been shown that the release of bacteriolytic enzymes is a property common to other bacteria of great importance for human pathology, such as enterococci and Pseudomonas aeruginosa (16, 18) . On the basis of the results obtained with the Cl-10/11 MAb, it is likely that antibodies, specifically reacting with epitopes characteristic of the bacteriolytic enzymes produced by the above-mentioned microorganisms, can be selected and used, in an assay similar to that here described, for the rapid and correct identification of these pathogens.
